Candidate MHC class I and II binding VH peptides
Position . | Residues . | Name . | Predicted MHC restriction* . | Parker/Rammensee score . | Sequence . | Position . | Germ line . |
|---|---|---|---|---|---|---|---|
| 105 | 9 | D9L | Kd | 2400/28 | DYWGQGTTL | CDR3/Fr4 | No |
| Ld | 5/11 | ||||||
| 79 | 9 | A9T | Kd | 144/13 | AYMQLNSLT | Fr3 | Yes |
| 43 | 9 | K9I | Kd | 115/16 | KSLEWIGDI | Fr2/CDR2 | Yes |
| Ld | 5/14 | ||||||
| 94 | 9 | Y9Y | Kd | 60/10 | YYCARDRFY | Fr3/CDR3 | No |
| 78 | 9 | T9L | Kd | 48/13 | TAYMQLNSL | Fr3 | Yes |
| Ld | 5/12 | ||||||
| 75 | 9 | S9L | Kd | 40/16 | SSSTAYMQL | Fr3 | Yes |
| Ld | 30/20 | ||||||
| 63 | 9 | K9T | Kd | 29/18 | KFKGKATLT | CDR2/Fr3 | Yes |
| 52 | 9 | N9Y | Ld | 78/13 | NPNNGGTSY | CDR2 | Yes |
| 1 | 16 | E16A | IAd | P | EVQLQQSGPELVKPGA | L/Fr1 | Yes |
| 8 | 16 | G16K | IAd | P | GPELVKPGASVKMSCK | L/Fr1 | Yes |
| 29 | 17 | F17L | IEd | P | FTDYYMKWVKQSHGKSL | Fr1/CDR1/Fr2 | Yes |
| 56 | 15 | G15L | IEd | P | GGTSYNQKFKGKATL | CDR2/Fr3 | Yes |
| 65 | 16 | K16Y | IAd | P | KGKATLTVDKSSSTAY | Fr3 | Yes |
| 79 | 15 | A15V | IAd | P | AYMQLNSLTSEDSAV | Fr3 | Yes |
Position . | Residues . | Name . | Predicted MHC restriction* . | Parker/Rammensee score . | Sequence . | Position . | Germ line . |
|---|---|---|---|---|---|---|---|
| 105 | 9 | D9L | Kd | 2400/28 | DYWGQGTTL | CDR3/Fr4 | No |
| Ld | 5/11 | ||||||
| 79 | 9 | A9T | Kd | 144/13 | AYMQLNSLT | Fr3 | Yes |
| 43 | 9 | K9I | Kd | 115/16 | KSLEWIGDI | Fr2/CDR2 | Yes |
| Ld | 5/14 | ||||||
| 94 | 9 | Y9Y | Kd | 60/10 | YYCARDRFY | Fr3/CDR3 | No |
| 78 | 9 | T9L | Kd | 48/13 | TAYMQLNSL | Fr3 | Yes |
| Ld | 5/12 | ||||||
| 75 | 9 | S9L | Kd | 40/16 | SSSTAYMQL | Fr3 | Yes |
| Ld | 30/20 | ||||||
| 63 | 9 | K9T | Kd | 29/18 | KFKGKATLT | CDR2/Fr3 | Yes |
| 52 | 9 | N9Y | Ld | 78/13 | NPNNGGTSY | CDR2 | Yes |
| 1 | 16 | E16A | IAd | P | EVQLQQSGPELVKPGA | L/Fr1 | Yes |
| 8 | 16 | G16K | IAd | P | GPELVKPGASVKMSCK | L/Fr1 | Yes |
| 29 | 17 | F17L | IEd | P | FTDYYMKWVKQSHGKSL | Fr1/CDR1/Fr2 | Yes |
| 56 | 15 | G15L | IEd | P | GGTSYNQKFKGKATL | CDR2/Fr3 | Yes |
| 65 | 16 | K16Y | IAd | P | KGKATLTVDKSSSTAY | Fr3 | Yes |
| 79 | 15 | A15V | IAd | P | AYMQLNSLTSEDSAV | Fr3 | Yes |
Position is the amino acid position of the VH sequence at which the peptides begin. Residues are the number of amino acids in the peptide. CDR indicates complementarity determining region; L, leader; and Fr, framework region. The Parker scores are estimated half-times of dissociation of the peptide from the MHC allele in minutes.41 The Rammensee scores are based on the relative contribution of amino acid residues and position on MHC binding.42 P indicates peptides selected using published binding motifs for MHC class II peptide-binding predictions.43
The MHC allele corresponding to the predicted binding score of Parker, Rammensee, or published motifs.